These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 6789494

  • 21. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
    Butt IF, Saeed SA, Waqar SN, Aslam M.
    J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
    Gasser JA, Betterridge DJ.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
    [Abstract] [Full Text] [Related]

  • 27. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 28. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL, Packham MA, Mustard JF.
    Thromb Haemost; 1984 Aug 31; 52(1):75-80. PubMed ID: 6495268
    [Abstract] [Full Text] [Related]

  • 29. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T, Werber MM, Guy R, Levanon A, Nimrod A, Legrand C, Gorecki M, Eldor A, Panet A.
    Arch Biochem Biophys; 1993 Jan 31; 300(1):501-9. PubMed ID: 8424687
    [Abstract] [Full Text] [Related]

  • 30. Changes in platelet response to adenosine 5'-diphosphate caused by verapamil.
    Walkowiak B, Koziołkiewicz W, Michalec L, Pawłowska Z, Krzesłowska J, Cierniewski CS.
    Pol J Pharmacol; 1996 Jan 31; 48(3):303-5. PubMed ID: 9112667
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W, Roth P, Weber PC.
    Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338
    [Abstract] [Full Text] [Related]

  • 36. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
    Steen VM, Holmsen H.
    Thromb Haemost; 1985 Oct 30; 54(3):680-3. PubMed ID: 4089798
    [Abstract] [Full Text] [Related]

  • 37. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW, Bennett JS, Sheridan JF, Cooper RA, Shattil SJ.
    J Lab Clin Med; 1976 Aug 30; 88(2):282-91. PubMed ID: 956686
    [Abstract] [Full Text] [Related]

  • 38. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H, Matthias FR, Lasch HG.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984 Aug 30; 111(6):761-8. PubMed ID: 6083951
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.